Skip to content

Primerica

US · PRI #1622 by market cap Listed 1970
286.76 -0.75 -0.26%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

✦ Quant Fair Value how this is computed

Below fair value
287.80 fair value ≈ 367.82 447.84
  • Implied fair-value range of 287.80-447.84, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is -22.0% below the average-multiple fair value of 367.82.

Valuation each multiple against its own 5-year range

P/B ratio 3.15 Cheap vs history 22nd percentile
5-year average 3.54 · #22 of 22 in Insurance - Life
P/E ratio 11.60 Cheap vs history 8th percentile
5-year average 16.06 · forward 11.29 · #10 of 18 in Insurance - Life
P/S ratio 2.55 In line with history 41st percentile
5-year average 2.53 · forward 2.42 · #20 of 22 in Insurance - Life

Vs. peers Insurance - Life

Company Market cap P/E (TTM) P/B Div yield
Primerica (PRI) 8.70B 11.33 3.08 1.62%
Manulife Financial (MFC) 67.55B 16.80 2.04 3.26%
Aflac Inc (AFL) 61.49B 18.15 2.10 1.94%
MetLife (MET) 60.12B 12.51 2.71 2.43%
Prudential Financial (PRU) 40.38B 10.72 1.37 4.71%
Prudential (PUK) 29.79B 8.51 1.50 2.20%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value271.87 Economic moatNarrow UncertaintyMedium

Trading 5.2% above Morningstar's fair value estimate.

Fair value

Primerica Inc earns a 3-star quantitative star rating, reflecting our opinion that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 8% premium over our quantitative fair value estimate of $271.87 per share; however, this estimate should be taken with a pinch of salt due to its medium uncertainty rating. We require the price/fair value ratio to move a certain amount before the star rating can change. This stability-enhancing buffer is in effect for this stock.

The company's valuation metrics weaken our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 31.9%, which sits in the bottom 30% compared with peers globally. The market value of this company's shares looks expensive relative to the book (accounting) value of equity, which contributes to our view that shares are overvalued.

Conversely, the company's profitability is reassuring. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's earnings yield of 8.9%, a core component of profitability, ranks in the top 30% globally. This suggests that it is generating substantial earnings relative to its share price, which, despite our unfavorable price/fair value ratio, is a positive attribute.

In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has outperformed the broader universe over the past year. This outperformance may signify a bull trap, in light of other detractors from our model.

Economic moat

The company's narrow quantitative moat rating indicates it could outearn its cost of capital and maintain robust margins for 10 years or longer. Its moat is bolstered by its strong financial health, which indicates low near-term bankruptcy risk.

By Quantitative Equity Report

Quote time 2026-11-20 20:02:15 · For reference only, not investment advice and not tailored to your situation.

Primerica discussion 0 comments

Add a comment